A Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar Surgical
Listen now
Description
For today’s episode, the newest addition to the OIS Podcast team, Carey Powers, sits down with the newest additions to the Staar Surgical team: Warren Foust, Chief Operating Officer; and Magda Michna, PhD, Chief Clinical, Regulatory, and Medical Affairs Officer. Starr has led the way in implantable lenses for over 40 years, but like many medical device companies, not many patients have heard of them. That’s changing now that Staar has doubled down on direct-to-consumer advertising. To date, they’ve secured collaborations with the Jonas Brothers, Peyton List, and NBA player Max Strus, among others. Kudos from celebrities, as well as a 99.4% patient satisfaction rate, will help Staar emulate the company’s success in the Asia-Pacific region and Europe in the United States. A clinical strategy that includes physician partnerships will help those docs communicate the safety profile and benefits of Staar’s EVO-ICL lenses for myopia and astigmatism. Listen to the podcast today to discover: Starr Surgical’s approach to physician partnerships and patient education.Why Starr decided to integrate its clinical, regulatory, and medical affairs teams and Dr. Michna’s vision for all three.How Starr Surgical plans and executes its advertising and marketing campaigns, including influencer campaigns.Foust and Dr. Michna’s thought process behind making the move to Starr Surgical from Johnson & Johnson and AcuFocus, respectively.[Press Play] Resources Staar Surgical                          https://www.staar.com/ Carey Powers                          https://ois.net/carey-powers/
More Episodes
In this episode of Eye on Innovation Podcast, Carey Powers delves into the latest advancements in corneal crosslinking technology with expert guest Dr. Deepinder Dhaliwal. Dr. Dhaliwal, a renowned professor of ophthalmology at the University of Pittsburgh School of Medicine and director of...
Published 06/21/24
In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover:Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion BiotechThe innovative allogenic cell therapy...
Published 06/07/24